United States · FDA National Drug Code directory

Rivastigmine Transdermal System

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
63629-8807_728327eb-6899-4802-a7f2-a68bb7c97c3e
Product NDC
63629-8807
Form
PATCH, EXTENDED RELEASE
Composition / generic term
Rivastigmine
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20191219
Source listing expiry
20261231

Source-listed ingredients

  • RIVASTIGMINE — 9.5 mg/24h

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 POUCH in 1 CARTON (63629-8807-1) / 1 PATCH in 1 POUCH (63629-8807-2) / 24 h in 1 PATCH · 63629-8807-1

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →